Mark Effingham
- Genetics top 0.5%
- Genetic Associations and Epidemiology 4
- Genomics and Rare Diseases 2
- Genetic Syndromes and Imprinting 1
- Diabetes and associated disorders 1
- Biological Psychiatry top 5%
- Health Informatics top 5%
- Aging top 5%
- Physiology top 5%
-
- Cancer Genomics and Diagnostics 3
-
- COVID-19 Clinical Research Studies 2
- SARS-CoV-2 and COVID-19 Research 1
-
- Single-cell and spatial transcriptomics 1
- Co-authors
- Naomi E. AllenOlivier DelaneauSamantha WelshAllan MotyerPeter DonnellyAdrián CortésClare BycroftLloyd T. Elliott
- Journals
- Nature (1 paper)Journal of Internal Medicine (1 paper)Journal of Epidemiology & Community Health (1 paper)
- Partner nations
- United KingdomUnited StatesAustralia
In The Last Decade
Mark Effingham
7 papers receiving 4.5k citations
Hit Papers
Peers
Comparison fields: 5 of 148
- Genetics 2.2k
- Biological Psychiatry 68
- Health Informatics 31
- Aging 39
- Physiology 467
Countries citing papers authored by Mark Effingham
This map shows the geographic impact of Mark Effingham's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Mark Effingham with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Mark Effingham more than expected).
Fields of papers citing papers by Mark Effingham
This network shows the impact of papers produced by Mark Effingham. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Mark Effingham. The network helps show where Mark Effingham may publish in the future.
Co-authorship network
The 25 scholars most cited alongside Mark Effingham, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2024 | 16 | |
| 2 | 2023 | 1 | |
| 3 | 2023 | 10 | |
| 4 | 2023 | 1 | |
| 5 | 2022 | 70 | |
| 6 | 2019 | 63 | |
| 7 | The UK Biobank resource with deep phenotyping and genomic databreakdown → | 2018 | 4399 |
About Mark Effingham
Mark Effingham is a scholar working on Modeling and Simulation, Cancer Research and Genetics, having authored 7 papers that have together received 4.6k indexed citations. Recurring topics across this work include Genetic Associations and Epidemiology (4 papers), Cancer Genomics and Diagnostics (3 papers), Genomics and Rare Diseases (2 papers), COVID-19 Clinical Research Studies (2 papers), Genetic Syndromes and Imprinting (1 paper), Diabetes and associated disorders (1 paper), Single-cell and spatial transcriptomics (1 paper) and SARS-CoV-2 and COVID-19 Research (1 paper). The work is most often cited by research in Genetics (2.2k citations), Biological Psychiatry (68 citations) and Health Informatics (31 citations). Mark Effingham has collaborated with scholars based in United Kingdom, United States and Australia. Frequent co-authors include Naomi E. Allen, Olivier Delaneau, Samantha Welsh, Allan Motyer, Peter Donnelly, Adrián Cortés, Clare Bycroft, Lloyd T. Elliott, Gil McVean and Jared O’Connell. Their work appears in journals such as Nature, Journal of Internal Medicine, Journal of Epidemiology & Community Health, Nature Communications and Nature Reviews Genetics.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.